July Nymex natural gas (NGN26 ) on Monday fell -0.111 (-3.37%). Nat-gas prices on Monday edged up to a new 2-month high but then fell back and closed sharply lower. Nat-gas prices fell back amid weather forecasts by Vaisala of cooler weather in the East for June 6-10, although above-normal...
July Nymex natural gas (NGN26 ) on Monday fell -0.111 (-3.37%). Nat-gas prices on Monday edged up to a new 2-month high but then fell back and closed sharply lower. Nat-gas prices fell back amid weather forecasts by Vaisala of cooler weather in the East for June 6-10, although above-normal...
Dell Technologies (NYSE:DELL) has become one of the market’s biggest AI winners. The stock has rocketed over 250% year to date and more than 100% in the past month alone, fueled by explosive demand for AI infrastructure. Yet even some bulls are beginning to question how much future growth is already reflected in the share ... Analyst Says Dell’s Momentum Is Real, But Valuation Is Risky with Stock ...
Dell Technologies (NYSE:DELL) has become one of the market’s biggest AI winners. The stock has rocketed over 250% year to date and more than 100% in the past month alone, fueled by explosive demand for AI infrastructure. Yet even some bulls are beginning to question how much future growth is already reflected in the share ... Analyst Says Dell’s Momentum Is Real, But Valuation Is Risky with Stock Up 250% YTD
Club slashed women’s team budget despite near-promotion Head coach resigned after decision players called ‘cold and impersonal’ Plymouth Argyle have said they “did not take lightly” their decision to significantly reduce their women’s team’s budget and tell the squad via email that their contracts were not being renewed. The Guardian reported on Sunday evening that the vast majority of the squad h...
Club slashed women’s team budget despite near-promotion Head coach resigned after decision players called ‘cold and impersonal’ Plymouth Argyle have said they “did not take lightly” their decision to significantly reduce their women’s team’s budget and tell the squad via email that their contracts were not being renewed. The Guardian reported on Sunday evening that the vast majority of the squad had received a letter, via email, which began abruptly with: “Hi all. Following our end-of-season review and planning for 2026-27, we wanted to let you know that we won’t be renewing contracts for the players included in this message.” Continue reading...
shulz/E+ via Getty Images Credo Technology ( CRDO ) shares dropped 10% after reporting its fourth quarter fiscal 2026 financial results post-market on Monday. Despite topping estimates across the board, the beat and outlook did not appear strong enough to satisfy all investors. For the quarter ended May 2, the high-speed connectivity solutions company reported adjusted earnings per share of $1.16 ...
shulz/E+ via Getty Images Credo Technology ( CRDO ) shares dropped 10% after reporting its fourth quarter fiscal 2026 financial results post-market on Monday. Despite topping estimates across the board, the beat and outlook did not appear strong enough to satisfy all investors. For the quarter ended May 2, the high-speed connectivity solutions company reported adjusted earnings per share of $1.16 versus the consensus estimate of $1.03. GAAP EPS was $0.88 compared to the $0.78 estimate. Revenue for the fourth quarter increased 157% year over year to $437M, which was more than the $433.3M estimate. "For the year, revenue more than tripled to $1.3B, and non-GAAP net income increased more than five times to $662M," said Credo CEO Bill Brennan. "As we enter into fiscal 2027, Credo expects to achieve continued strong financial performance with our innovative and vertically integrated approach that enables customers to accelerate cluster time-to-stability, maximize GPU utilization, improve network reliability, and reduce overall infrastructure power and operating costs." For the quarter in progress, Credo expects revenue to range from $465M to $475M, which clears the $460M estimate. It projects its adjusted gross margin to range from 67% to 69%, which all surpasses the 65% estimate. Although Credo's numbers surpassed estimates, they were not enough to satisfy the lofty goals of investors. "CRDO numbers, while robust, were clearly not enough to satisfy the market's expectations," said Julian Lin , Investing Group Leader for Best Of Breed Growth Stocks. "I suspect that the stock's selloff has less to do with the numbers and more to do with how rising semiconductor stock prices across the board may have created unrealistic expectations heading into the print." "We're seeing the same thing we saw roughly three months ago after Credo's Q3 results," noted Tech Stock Pros , Investing Group Leader for Tech Contrarians. "The results are good, but with the stock up 151% quarter-to-d...
Documents also reveal internal Labour criticism of Keir Starmer in embarrassing detail Peter Mandelson was receiving sensitive security briefings about the Foreign Office’s work, and was in discussions with the head of MI6, before he had completed the developed vetting process, newly released documents reveal. Declassified emails show the ambassador designate and Richard Moore, the former chief of...
Documents also reveal internal Labour criticism of Keir Starmer in embarrassing detail Peter Mandelson was receiving sensitive security briefings about the Foreign Office’s work, and was in discussions with the head of MI6, before he had completed the developed vetting process, newly released documents reveal. Declassified emails show the ambassador designate and Richard Moore, the former chief of MI6 – a role known as “C” – had agreed to meet in early January 2025 before Mandelson went to Washington. Continue reading...
Defense startup Mach Industries notched a $1.8 billion valuation in a funding deal to ramp up production of its autonomous aircraft, strike systems and other gear for the Pentagon and allied forces. Infinite Capital and Ribbit Capital co-led the $300 million funding round at more than three times Mach’s 2025 valuation, reflecting confidence in the California-based startup and the sector. Venture c...
Defense startup Mach Industries notched a $1.8 billion valuation in a funding deal to ramp up production of its autonomous aircraft, strike systems and other gear for the Pentagon and allied forces. Infinite Capital and Ribbit Capital co-led the $300 million funding round at more than three times Mach’s 2025 valuation, reflecting confidence in the California-based startup and the sector. Venture capitalists nearly doubled their investments in defense tech last year, plowing more than $49 billion into sector startups, on signs of continuing global conflict and the Pentagon’s growing appetite for nontraditional weapons. Chief Executive Officer Ethan Thornton told Bloomberg News he’ll use the fresh funds during the next year to more than double company headcount to 700 and increase production capacity from “tens of vehicles” to 1,000 each week. He declined to share specifics on products or revenue numbers. Thornton, who won initial support as a Thiel fellow, said he’s shifted Mach’s focus from developing hydrogen-based weapons systems to producing drones and other products for immediate use. Mach is also building toward supplying parts for its own weapons systems and those produced by other defense companies, he said. Raising the round was relatively easy, Thornton said, adding that he initially sought just $200 million and turned down offers for an additional $100 million. Founded in 2023 and based in Huntington Beach, California, Mach has raised roughly $485 million total from private investors including Sequoia Capital and Khosla Ventures . The company was valued at $470 million in 2025, the last time it raised capital.
aprott Moderna ( MRNA ) and Merck ( MRK ) said that the experimental cancer vaccine intismeran autogene plus Keytruda (pembrolizumab) led to a 49% decline in the risk of recurrence or death, and a 50% reduction in the risk of distant metastasis, compared to Keytruda alone, or death in patients with late-stage melanoma. The data is based on a median five-year follow-up of the phase 2 KEYNOTE-942/mR...
aprott Moderna ( MRNA ) and Merck ( MRK ) said that the experimental cancer vaccine intismeran autogene plus Keytruda (pembrolizumab) led to a 49% decline in the risk of recurrence or death, and a 50% reduction in the risk of distant metastasis, compared to Keytruda alone, or death in patients with late-stage melanoma. The data is based on a median five-year follow-up of the phase 2 KEYNOTE-942/mRNA-4157-P201. Overall survival, an exploratory endpoint, also showed a positive trend. Enrolled patients had high-risk stage III/IV melanoma. Intismeran autogene, known as an mRNA-individualized neoantigen therapy, is also under investigation by the two companies for other tumor types, including non-small cell lung cancer, bladder cancer, and renal cell carcinoma. More on Moderna, Merck Moderna, Inc. (MRNA) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript Merck & Co., Inc. (MRK) Shareholder/Analyst Call - Slideshow Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript EU to target XFG variant for next COVID vaccines FDA to cut animal testing in cancer drug development
The artificial intelligence boom has produced two very different winners in the software space. Choosing between SoundHound AI (NASDAQ:SOUN) and NICE (NASDAQ:NICE) requires weighing explosive revenue growth against steady, billion-dollar profitability. SoundHound AI focuses on voice-enabled interactions for cars, restaurants, and smart devices, while NICE dominates the back-end of customer service...
The artificial intelligence boom has produced two very different winners in the software space. Choosing between SoundHound AI (NASDAQ:SOUN) and NICE (NASDAQ:NICE) requires weighing explosive revenue growth against steady, billion-dollar profitability. SoundHound AI focuses on voice-enabled interactions for cars, restaurants, and smart devices, while NICE dominates the back-end of customer service through its cloud-based contact center platforms. Both companies are integrating advanced AI to automate human tasks and improve efficiency. This comparison evaluates their financials and risk profiles for retail investors looking at 2026. SoundHound AI ranks among the faster-growing tech stocks because of its specialized focus on conversational software. The company develops tools that allow users to speak naturally to devices like cars and restaurant kiosks. By targeting the automotive and retail industries, it aims to replace traditional touchscreens with agentic AI. For the year ended December 31, 2025, no single customer accounted for more than 10% of total revenues. Continue reading
Bloomberg's Joel Weber puts Katie Greifeld and Eric Balchunas to the test on "Bloomberg ETF IQ" in this week's edition of "IQ Test." (Source: Bloomberg)
Bloomberg's Joel Weber puts Katie Greifeld and Eric Balchunas to the test on "Bloomberg ETF IQ" in this week's edition of "IQ Test." (Source: Bloomberg)